Le Lézard
Classified in: Health
Subject: PER

SCCE & HCCA Announces Two New Appointments to Its Board of Directors


MINNEAPOLIS, Sept. 17, 2021 /PRNewswire/ -- Society of Corporate Compliance and Ethics® (SCCE) & Health Care Compliance Association® (HCCA) is pleased to announce the election of two new members to its Board of Directors taking office on November 1, 2021, and the re-election of five existing board members to new terms. 

The SCCE & HCCA Board of Directors is comprised of 19 individuals and represents a diverse group of compliance professionals who are dedicated to championing ethical practices and compliance standards in the community by providing oversight and leadership for the association. 

SCCE & HCCA's two new board members are:

Current board members who were elected to new terms are:

"I am thrilled with the backgrounds and expertise that these seven individuals bring to our organization. The mix of new and returning board members is precisely what we need to sustain our success and grow SCCE & HCCA," said Gerry Zack, CEO of SCCE & HCCA.

About SCCE & HCCA
Health Care Compliance Association® (HCCA) was founded in 1996 to serve the healthcare compliance profession and expanded in 2004 with the Society of Corporate Compliance and Ethics® (SCCE) to serve the global compliance and ethics community across all industries. With a combined 20,000 members in 100 countries, SCCE & HCCA is the largest association furthering the interests of the compliance and ethics profession. Headquartered in Minneapolis, MN, SCCE & HCCA exists to champion ethical practice and compliance standards and to provide the necessary training, publications, certifications, and other resources for ethics and compliance professionals.

Visit the SCCE website at www.corporatecompliance.org or call 888.277.4977

Visit HCCA's website at www.hcca-info.org or call 888.580.8373

SOURCE Society of Corporate Compliance and Ethics (SCCE) & Health Care Compliance Association (HCCA)


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: